Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5501760

N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C3\CCN(Cc4cc[n+](CC(=O)Nc5ccc(O)cc5)cc4)C3=O)CS[C@H]12.O=C([O-])C(F)(F)F

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.32
PTGS2 P35354 1/20 0.32
DRD3 P35462 1/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
PTPN11 Q06124 1/20 0.32
HDAC1 Q13547 1/20 0.31
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5501776 1.00 DRD2 (0.32) DRD2PTGS2DRD3MAPTMEN1
Trifluoroacetic Acid SCHEMBL5501745 0.96 DRD2 (0.33) DRD2PTGS2DRD3MAPTMEN1
Trifluoroacetic Acid SCHEMBL8707095 0.94 HDAC1 (0.31) HDAC1
Trifluoroacetic Acid SCHEMBL8707075 0.94 HDAC1 (0.31) HDAC1
Trifluoroacetic Acid SCHEMBL8707018 0.93 MAPT (0.33) DRD2PTGS2DRD3MAPTMEN1
Trifluoroacetic Acid SCHEMBL8705773 0.93 HDAC1 (0.33) MAPTTDP1POLBPKMHTT
Trifluoroacetic Acid SCHEMBL8703933 0.93 HSP90AA1 (0.35) MAPTMEN1KMT2ATDP1POLB
Trifluoroacetic Acid SCHEMBL8705695 0.92 HDAC1 (0.31) MAPTTDP1POLBPKMHTT
Trifluoroacetic Acid SCHEMBL5507641 0.92 HDAC1 (0.34) MAPTTDP1POLBPKMHTT
Trifluoroacetic Acid SCHEMBL5507637 0.92 HDAC1 (0.34) MAPTTDP1POLBPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841339-B1 Vinylpyrrolidinon cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-02-21 EP disclosed
EP-0911030-B1 Antimicrobial composition comprising a vinyyl pyrrolidinon derivative and a carbapenem antibiotic or a beta-lactamase inhibitor BASILEA PHARMACEUTICA AG (CH) 2005-04-13 EP disclosed
US-6294668-B1 ANTIBACTERIAL ACTIVITY AGAINST BETA-LACTAM SENSITIVE AND RESISTANT GRAM-POSITIVE BACTERIA, SUCH AS STAPHYLOCOCCI, PNEUMOCOCCI, AND ENTEROCOCCI; USED IN THERAPY OF INFECTIOUS DISEASES CAUSED BY THOSE BACTERIA HOFFMAN-LA ROCHE INC. 2001-09-25 US disclosed
US-6150350-A CARBAPENEM ANTIBIOTIC AND BETA-LACTAMASE INHIBITOR, USEFUL FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES HOFFMAN-LA ROCHE INC. (US) 2000-11-21 US disclosed
EP-0911030-A2 Antimicrobial composition comprising a vinyyl pyrrolidinon derivative and a carbapenem antibiotic or a beta-lactamase inhibitor F.HOFFMANN-LA ROCHE AG (CH) 1999-04-28 EP disclosed
EP-0841339-A1 Vinylpyrrolidinon cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-05-13 EP disclosed
EP-0838465-A1 Pyridinium-substituted (lactamylvinyl)cephalosporin derivatives, their preparation and their use as antibiotics F. HOFFMANN-LA ROCHE AG (CH) 1998-04-29 EP disclosed